Literature DB >> 9008266

The distribution of 10-hydroxy carbazepine in blood compartments.

H Jung1, A Noguez, L Mayet, I Fuentes, D F González-Esquivel.   

Abstract

The distribution of 10-hydroxy carbazepine (MHD), the main metabolite of oxcarbazepine (OXC), was investigated in plasma and red cells. After the oral administration of 600mg of OXC to nine healthy volunteers, blood samples were withdrawn for the next 56h and packed red cells were separated from plasma by centrifugation. Also, in vitro studies of plasma binding of MHD were carried out by a dialysis technique. Results showed that the in vitro protein binding was low. The mean bound concentration ranged from 37 to 40%; however, an affinity of MHD to red corpuscles was found. These observations indicate that MHD red blood cell concentrations together with plasma measurements could be useful in cases of inefficacy or toxicity in order to make the appropriate drug adjustments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008266     DOI: 10.1002/(sici)1099-081x(199701)18:1<17::aid-bdd997>3.0.co;2-r

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

1.  Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine.

Authors:  Anna Maria Mauro; Chiara Bomprezzi; Simonetta Morresi; Leandro Provinciali; Francesco Formica; Maurizio Iacoangeli; Massimo Scerrati
Journal:  J Neurooncol       Date:  2006-08-31       Impact factor: 4.130

Review 2.  Oxcarbazepine: an update of its efficacy in the management of epilepsy.

Authors:  K Wellington; K L Goa
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Spotlight on oxcarbazepine in epilepsy.

Authors:  Lynne M Bang; Karen L Goa
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Oxcarbazepine: a review of its use in children with epilepsy.

Authors:  Lynne Bang; Karen Goa
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Clinical pharmacokinetics of oxcarbazepine.

Authors:  Theodor W May; Elisabeth Korn-Merker; Bernhard Rambeck
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.